New COVID-19 project

We are investigating new blocking strategies for SARS-CoV-2 virus.

We were awarded with one of the prestigious grants from ANPCyT-Fundación Bunge & Born to develop new therapies that block virus infectivity and the associated immune-mediated pathology.